ARCHIVES

Critics of FDA misunderstand Bayesian analysis, statisticians say.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Neurocognitive Deficits Affect Future Adult Employment

September 30, 2011

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

NCAB Orders 23 Unfunded Organ Site Grants Paid, Sends Contradictory Messages On Program Revisions

December 3, 1982

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

John Montgomery Named to Replace Harold Amos On Cancer Panel

April 8, 1983

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012